BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36681140)

  • 1. Impaired kynurenine metabolism in patients with primary Sjögren's syndrome.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sak F; Humeyra Yerlikaya F; Yilmaz S; Abusoglu G; Kazim Korez M; Unlu A
    Clin Biochem; 2023 Apr; 114():1-10. PubMed ID: 36681140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum levels of kynurenine pathway metabolites in patients with Behçet disease.
    Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sivrikaya A; Kuzu M; Yerlikaya FH; Yilmaz S; Unlu A
    Amino Acids; 2022 Jun; 54(6):877-887. PubMed ID: 35604497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus.
    Eryavuz Onmaz D; Tezcan D; Yilmaz S; Onmaz M; Unlu A
    Amino Acids; 2023 Dec; 55(12):1937-1947. PubMed ID: 37925676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Kynurenine Levels in Patients with Primary Sjögren's Syndrome.
    Apaydın H; Koca Bicer C; Feyza Yurt E; Abdulkadir Serdar M; Dogan İ; Erten S
    Lab Med; 2023 Mar; 54(2):166-172. PubMed ID: 36053233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
    Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
    J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms dependent on tryptophan catabolism regulate immune responses in primary Sjögren's syndrome.
    Pertovaara M; Raitala A; Uusitalo H; Pukander J; Helin H; Oja SS; Hurme M
    Clin Exp Immunol; 2005 Oct; 142(1):155-61. PubMed ID: 16178870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
    Ryan KM; Allers KA; McLoughlin DM; Harkin A
    Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever.
    Tezcan D; Onmaz DE; Sivrikaya A; Körez MK; Hakbilen S; Gülcemal S; Yılmaz S
    Mod Rheumatol; 2023 Mar; 33(2):398-407. PubMed ID: 35139221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of periodontal inflammation on tryptophan-kynurenine metabolism: a cross-sectional study.
    Kurgan Ş; Önder C; Balcı N; Akdoğan N; Altıngöz SM; Serdar MA; Günhan M
    Clin Oral Investig; 2022 Sep; 26(9):5721-5732. PubMed ID: 35588020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the kynurenine pathway in human glioma pathophysiology.
    Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
    PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
    Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
    Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
    Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous measurement of kynurenine metabolites and explorative metabolomics using liquid chromatography-mass spectrometry: A novel accurate method applied to serum and plasma samples from a large healthy cohort.
    Eggertsen PP; Hansen J; Andersen ML; Nielsen JF; Olsen RKJ; Palmfeldt J
    J Pharm Biomed Anal; 2023 Apr; 227():115304. PubMed ID: 36827735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
    Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
    Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid kynurenines in multiple sclerosis; relation to disease course and neurocognitive symptoms.
    Aeinehband S; Brenner P; Ståhl S; Bhat M; Fidock MD; Khademi M; Olsson T; Engberg G; Jokinen J; Erhardt S; Piehl F
    Brain Behav Immun; 2016 Jan; 51():47-55. PubMed ID: 26189678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenine pathway changes in late-life depression with memory deficit.
    Wu Y; Mai N; Zhong X; Wen Y; Zhou Y; Li H; Shang D; Hu L; Chen X; Chen B; Zhang M; Ning Y
    Psychiatry Res; 2018 Nov; 269():45-49. PubMed ID: 30145300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.